Norimatsu Y, Ohmori T, Kimura A, Madoiwa S, Mimuro J, Seichi A, et al. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. Am J Pathol. 2012;180:1625–35.

Article  CAS  PubMed  Google Scholar 

Lee KD, Chow WN, Sato-Bigbee C, Graf MR, Graham RS, Colello RJ, et al. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J Neurotrauma. 2009;26:2335–44.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu R, Cai W, Jiang L, Chen K, Shi J, et al. Davunetide promotes structural and functional recovery of the injured spinal cord by promoting autophagy. Neural Regen Res. 2025;1:10–4103.

Zhang H, He K, Zhao Y, Peng Y, Feng D, Wang J, et al. fNIRS biomarkers for stratifying poststroke cognitive impairment: Evidence from frontal and temporal cortex activation. Stroke. 2025;56:3245–56.

Article  CAS  PubMed  Google Scholar 

Xu G, Huo C, Yin J, Zhong Y, Sun G, Fan Y, et al. Test-retest reliability of fNIRS in resting-state cortical activity and brain network assessment in stroke patients. Biomed Opt Express. 2023;14:4217–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shirzad S, Riyahi Rad M, Rezaei M, Tayaranian Marvian M, Abroumand Gholami A, Forouzanfar F, et al. Effect of pretreatment with Devil’s Claw on locomotor activity, infarct volume, and neuronal density in focal cerebral ischemia in rats. Avicenna J Phytomedicine. 2024;14:485–95.

Google Scholar 

Forghani N, Hosseinian S, Akhoond-Ali Z, Gholami AA, Assaran-Darban R, Vafaee F. Effect of acute and chronic stress on memory impairment and hippocampal oxidative stress following global cerebral ischemia in adult male rats. Res Pharm Sci. 2024;19:436–46.

Article  PubMed  PubMed Central  Google Scholar 

Asadi-Pooya AA, Malekpour M, Taherifard E, Mallahzadeh A, Kouhanjani MF. Coexistence of temporal lobe epilepsy and idiopathic generalized epilepsy. Epilepsy Behav. 2024;151:109602.

Article  PubMed  Google Scholar 

Malekpour M, Jafari A, Kashkooli M, Salarikia SR, Negahdaripour M. A systems biology approach for discovering the cellular and molecular aspects of psychogenic non-epileptic seizure. Front Psychiatry. 2023;14:1116892.

Article  PubMed  PubMed Central  Google Scholar 

WHO. WHO. 2024. https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury.

Abroumand Gholami A, Tahmasebi F, Haghir H, Babaloo H. Targeting JAK/STAT signaling pathway by curcumin: Implications for spinal cord injury neuroprotection. Inflammopharmacology. 2025;33:1–19.

Jin Y, Song Y, Lin J, Liu T, Li G, Lai B, et al. Role of inflammation in neurological damage and regeneration following spinal cord injury and its therapeutic implications. Burn Trauma. 2023;11:tkac054.

Article  Google Scholar 

Bhatt M, Sharma M, Das B. The role of inflammatory cascade and reactive astrogliosis in glial scar formation post-spinal cord injury. Cell Mol Neurobiol. 2024;44:1–18.

Article  Google Scholar 

Shirzad S, Tayaranian Marvian M, Abroumand Gholami A, Gharehbaghi M, Marefati N, Salmani H, et al. Unveiling the effects of left hemispheric intracerebral hemorrhage on long-term potentiation and inflammation in the bilateral hippocampus: A preclinical study. J Stroke Cerebrovasc Dis [Internet]. 2024;33:107523. Available from: https://www.sciencedirect.com/science/article/pii/S105230572300544X.

Lukacova N, Kisucka A, Kiss Bimbova K, Bacova M, Ileninova M, Kuruc T, et al. Glial-neuronal interactions in pathogenesis and treatment of spinal cord injury. Int J Mol Sci. 2021;22:13577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Wang J, Jiang J, Song J, Zhu W, Zhang F, et al. TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K/AKT pathway after spinal cord injury. Cell Death Dis. 2020;11:693.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abroumand Gholami A, Gheybi F, Molavi AM, Tahmasebi F, Papi A, Babaloo H. Effect of polycaprolactone/carbon nanotube scaffold implantation along with liposomal ellagic acid in hippocampal synaptogenesis after spinal cord injury. Nanomedicine J [Internet]. 2023;10:197–209. Available from: https://nmj.mums.ac.ir/article_22560.html.

Google Scholar 

Babaloo H, Barati S, Haghir H, Gholami AA, Moharreri P, Fallahnezhad S, et al. The effect of PU/MWCNT nanofiber scaffolds containing hesperidin nanoparticles and mesenchymal stem cells on the microglia and astrocyte phenotype in the spinal cord injury model. Neuroscience. 2025;583:53–62.

Article  CAS  PubMed  Google Scholar 

Wu W, Lee SY, Wu X, Tyler JY, Wang H, Ouyang Z, et al. Neuroprotective ferulic acid (FA)–glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord. Biomaterials. 2014;35:2355–64.

Article  CAS  PubMed  Google Scholar 

Zou GJ, Chen ZR, Wang XQ, Cui YH, Li F, Li CQ, et al. Microglial activation in the medial prefrontal cortex after remote fear recall participates in the regulation of auditory fear extinction. Eur J Pharmacol [Internet]. 2024;978:176759. Available from: https://www.sciencedirect.com/science/article/pii/S0014299924004473.

Article  CAS  PubMed  Google Scholar 

Zeng WJ, Zhang L, Cao H, Li D, Zhang H, Xia Z, et al. A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma. Front Immunol. 2022;13:810572.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mortezaee K, Khanlarkhani N, Beyer C, Zendedel A. Inflammasome: its role in traumatic brain and spinal cord injury. J Cell Physiol. 2018;233:5160–9.

Article  CAS  PubMed  Google Scholar 

Jiang W, Li M, He F, Zhou S, Zhu L. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice. J Neuroinflammation. 2017;14:1–12.

Article  Google Scholar 

Mankan AK, Dau T, Jenne D, Hornung V. The NLRP3/ASC/Caspase‐1 axis regulates IL‐1β processing in neutrophils. Eur J Immunol. 2012;42:710–5.

Article  CAS  PubMed  Google Scholar 

Luo J, Li X, Zhang L, Deng M, Zhao J, Zhang J, et al. 5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation. Front Pharmacol. 2025;16:1522146.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dominic A, Le NT, Takahashi M. Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal. 2022;36:784–96.

Article  CAS  PubMed  Google Scholar 

Doyle TM, Chen Z, Durante M, Salvemini D. Activation of sphingosine-1-phosphate receptor 1 in the spinal cord produces mechanohypersensitivity through the activation of inflammasome and IL-1β pathway. J pain. 2019;20:956–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bascuñana P, Möhle L, Brackhan M, Pahnke J. Fingolimod as a treatment in neurologic disorders beyond multiple sclerosis. Drugs R D. 2020;20:197–207.

Article  PubMed  PubMed Central  Google Scholar 

Malhotra S, Hurtado-Navarro L, Pappolla A, Villar LMM, Río J, Montalban X, et al. Increased NLRP3 inflammasome activation and pyroptosis in patients with multiple sclerosis with fingolimod treatment failure. Neurol Neuroimmunol Neuroinflammation. 2023;10:e200100.

Article  Google Scholar 

Leo A, Citraro R, Marra R, Palma E, Donato Di Paola E, Constanti A, et al. The sphingosine 1-phosphate signaling pathway in epilepsy: A possible role for the immunomodulator drug fingolimod in epilepsy treatment. CNS Neurol Disord Targets-CNS Neurol Disord. 2017;16:311–25.

Article  CAS  Google Scholar 

Doolen S, Iannitti T, Donahue RR, Shaw BC, Grachen CM, Taylor BK. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn. Pain. 2018;159:224–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poormoghadam D, Shiadeh BR, Azedi F, Tavakol H, Rezayat SM, Tavakol S. Fingolimod nanoemulsions at different particle sizes define the fate of spinal cord injury recovery. Biomed Res Int. 2022;2022:5703426.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Chen Y, Hu X, Ouyang F, Li J, Huang J, et al. Fingolimod (FTY720) hinders Interferon-γ-mediated fibrotic scar formation and facilitates neurological recovery after spinal cord injury. J Neurotrauma. 2023;40:2580–95.

Article  PubMed